You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Profile for Argentina Patent: 085749


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 085749

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Sep 30, 2032 Novartis GILENYA fingolimod hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Last updated: August 5, 2025

tailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR085749


Introduction

Argentina’s pharmaceutical patent landscape is characterized by its adherence to international standards yet displays unique national legal nuances. Patent AR085749 is a notable patent within this framework, warranting a detailed examination of its scope, claims, and the broader patent landscape. This report aims to elucidate these aspects, supporting stakeholders in strategic decision-making related to licensing, infringement risk, and market exclusivity.


Patent Overview and Context

Patent AR085749, filed and granted within Argentina's patent office, pertains to a pharmaceutical compound or formulation—specific details of which are available from the patent document. Argentina’s Patent and Trademark Office (INPI) grants patents with a validity period of 20 years from the filing date, provided maintenance fees are paid annually. This patent's filing date, priority claims, and issue date are necessary to establish its current legal status, approximate expiration, and enforceability window.

Scope and Claims Analysis

Scope of patent AR085749:

The scope of a patent chiefly resides in its claims—precise legal boundaries delineating the exclusive rights conferred by the patent. Analyzing AR085749’s claims offers insight into the patent's breadth and enforceability.

Type and breadth of claims:

  1. Product Claims:
    The patent likely contains claims directed toward a specific chemical compound, its derivatives, or salts. These claims specify the molecular structure, stereochemistry, or a unique synthesis process. Product claims grant broad exclusivity over the compound itself, potentially covering all uses and formulations involving this entity within Argentina.

  2. Use or Method Claims:
    Additional claims may cover novel methods of manufacturing or specific therapeutic or diagnostic uses of the compound. Use claims can extend patent protection to particular medical indications or methods of administration, offering strategic exclusivity.

  3. Formulation Claims:
    Claims may encompass specific formulations, such as sustained-release versions or combination products, broadening the patent's coverage over different pharmaceutical embodiments.

Claim language intricacies:

  • Claimed molecules are often defined by structural formulas, with optional substituents, which determine the scope's breadth. Narrow claims specify particular substituents or stereochemistry, while broader claims may encompass a class of compounds.

  • The claims' dependency structure influences enforceability; independent claims set the broadest scope, while dependent claims specify particular embodiments or advantages.

Legal and technical limitations:

  • Argentinian patent law requires claims to be supported by the description, and claims that are overly broad relative to disclosures might face invalidation.

  • Argentine patent law incorporates a law of novelty, inventive step, and industrial applicability, thus claims must satisfy these criteria—particularly inventive step—limiting overly obvious variations.

Patent Landscape and Market Implications

Patent family and existing disclosures:

It’s critical to examine whether AR085749 belongs to a patent family with global counterparts—e.g., filings in WIPO (PCT), INPI Brazil, or other Latin American jurisdictions. A broader patent family suggests a strategic patent portfolio and may impact generic entry opportunities in Argentina.

Competitor activity and patenting trends:

  • The Argentine pharmaceutical patent landscape features a mix of local innovation and patent filings by multinational corporations (MNCs).
  • The government’s stance on patents and access to medicines influences patent enforcement, especially for essential drugs.

Freedom-to-operate considerations:

  • The scope of AR085749’s claims must be evaluated against existing patents and prior art to assess infringement risks and licensing opportunities.
  • The presence of overlapping patents or prior disclosures can limit commercialization or prompt design-around strategies.

Legal status and maintenance:

  • The patent’s current status—whether maintained, opposed, or challenged—is essential. Argentina’s INPI publishes legal status updates. An expiration or invalidation would open the market to generics.

Impact on market exclusivity:

  • If AR085749 claims a novel chemical entity or a unique formulation, it provides a significant market barrier for generic manufacturers until its expiration.
  • Conversely, narrow claims or prior art limitations could diminish exclusivity periods.

Regulatory and Enforcement Landscape

Argentina’s regulatory regime—administered by ANMAT (National Administration of Drugs, Food and Medical Technology)—requires patent status to influence marketing and patent rights. Enforcement actions are governed by the Argentine Civil and Commercial Code, with specialized courts handling infringement cases.

Potential challenges include:

  • Patent challenges or oppositions: Initiated by third parties during the patent’s life.
  • Patent expiry: Leading to market entry and increased competition.
  • Legal enforcement: Including injunctions, damages, and settlement considerations.

Summary of Key Patent Considerations

  • Claims Breadth: The core patent claims likely define a specific chemical entity or formulation, with potential for broad or narrow interpretation.

  • Legal Validity: Bound by Argentine patent law’s requirements for novelty, inventive step, and industrial application. Validity may be challenged during enforcement or oppositions.

  • Market Impact: AR085749’s patent rights confer exclusivity, impacting pricing, market share, and generic entry. The patent’s scope directly influences business strategies.

  • Landscape Dynamics: The patent landscape is shaped by regional filings, patent family relations, and evolving legal standards, all of which influence strategic decision-making.


Key Takeaways

  • A detailed claims analysis is essential: Carefully evaluate the language for scope, dependencies, and vulnerabilities.
  • Monitor legal status: Expiration dates, oppositions, or legal challenges directly affect patent value and market strategies.
  • Understand local patent laws: Argentina's legal framework influences patent enforceability, especially regarding pharmaceutical products.
  • Broaden landscape understanding: Identify patent families and regional filings to assess competitive position and licensing opportunities.
  • Strategic planning: Use patent scope and landscape insights to optimize R&D pathways, infringement defenses, and market entry timing.

Frequently Asked Questions (FAQs)

Q1: How does Argentine patent law treat pharmaceutical patent claims regarding obviousness?
A1: Argentine law mandates that patent claims demonstrate an inventive step above prior art. Claims deemed obvious based on existing disclosures are invalid, necessitating careful drafting and substantive examination of prior art during prosecution.

Q2: Can a patent with narrow claims still provide meaningful market exclusivity?
A2: Yes. Narrow claims targeting specific compounds or formulations can yield significant exclusivity if they cover unique or therapeutically valuable embodiments; however, broader claims generally offer stronger protection.

Q3: How does Argentina’s patent landscape compare with neighboring Latin American countries?
A3: Argentina’s patent law aligns with WIPO standards, but each country has unique nuances. Argentina generally offers robust protections for patented pharmaceuticals, though enforcement can vary regionally.

Q4: What are typical pathways for challenging a patent like AR085749?
A4: Challenges can be filed via oppositions during patent prosecution or through post-grant nullity proceedings based on prior art, lack of inventive step, or insufficient disclosure.

Q5: How should companies approach patent landscape analysis for Argentine drugs?
A5: Companies should identify patent family members, monitor patent expirations, assess claim scope relative to prior art, and evaluate legal and market risks before launching generics or new formulations.


Conclusion

Patent AR085749 exemplifies the sophisticated intersection of claim scope, legal validity, and market exclusivity within Argentina’s pharmaceutical patent landscape. An incisive analysis of its claims and strategic positioning amidst regional patent activity can significantly influence a company's regulatory, legal, and commercial decisions. Continuous monitoring of legal status and competitor activity, coupled with precise claim interpretation, remains vital in capitalizing on or navigating around Argentine pharmaceutical patents.


Sources

[1] Argentine Patent Office (INPI). Official patent documents and legal status updates.
[2] World Intellectual Property Organization (WIPO). Patent family and international filings info.
[3] Argentine Patents Law (Law No. 24,481).
[4] International Bureau of WIPO. Patent landscape reports and legal standards.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.